BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 3, 2008
View Archived Issues
Synergistic antimicrobial drug combinations may favor the development of resistance
Read More
Eupatilin induces apoptosis in colon cancer cell line
Read More
Novel compounds intended for treatment of obesity reported in recent patents
Read More
Tamsulosin-tolterodine ER combination improves ureteral stent-related urinary symptoms
Read More
Recent patents impart new oncolytic drugs
Read More
TRC-105 tolerated, active in ongoing phase I cancer study
Read More
Galapagos and CHDI sign new collaboration agreements in Huntington's disease
Read More
Osaka University patents compounds for treatment of periodontitis
Read More
Affitech acquires diabody technology from Pharmexa
Read More
Graffinity signs global multidrug discovery collaboration with AstraZeneca
Read More
Pharmexa and Kael enter into an agreement regarding GV-1001
Read More
New radiotherapeutic shows promising results in murine and primate melanoma models
Read More
Novel antisense oligonucleotide safe in preliminary data from phase I advanced cancer study
Read More
FDA approves Kringle's IND to initiate phase I trial of recombinant human HGF in ARF
Read More
FDA approves new indication for Hospira's Precedex in nonintubated patients
Read More
Biogen and Genentech to develop and commercialize GA-101 in the U.S.
Read More
Aastrom achieves milestone in U.S. phase IIb critical limb ischemia trial
Read More
Anadys commences dosing of ANA-773 in hepatitis C patients
Read More
Bayhill and Juvenile Diabetes Research Foundation enter research collaboration
Read More
RAPID 1 study shows Cimzia rapidly reduces symptoms and progression of RA
Read More
Spectrum files sNDA with FDA for Fusilev in colorectal cancer
Read More
Polyphor signs exclusive agreement with Allergan for PEM inhibitors in ophthalmology
Read More
FDA approves fesoterodine for overactive bladder
Read More
Apriso approved by FDA for ulcerative colitis
Read More
Savient submits BLA to FDA for pegloticase
Read More
